John Friend

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

Jennifer S. Temel, Amy P. Abernethy, David C. Currow et al. · The Lancet Oncology · 2016 · 607 citations

Romana 2, Romana 1, Non-small-cell Lung Cancer +8

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials

José M. Garcia, Ralph V. Boccia, Charles D. Graham et al. · The Lancet Oncology · 2014 · 210 citations

Integrated Analysis, Cancer Cachexia, Medicine +11

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

David C. Currow, Jennifer S. Temel, Amy P. Abernethy et al. · Annals of Oncology · 2017 · 172 citations · Full text

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

José M. Garcia, John Friend, Suzan Allen · Supportive Care in Cancer · 2012 · 166 citations

Cancer-related Cachexia, Medicine, Metronomic Therapy +8

Blood flow in pulmonary veins: I Studies in dog and man

B. Rajagopalan, John Friend, T. J. Stallard et al. · Cardiovascular Research · 1979 · 119 citations

Left Atrial Pressure, Blood Flow, Hematology +16